 The Express Tribune |
Transitions: ‘Mozart of India‘ Ravi Shankar dies at 92
The Express Tribune The statement said Shankar had suffered from upper respiratory and heart issues over the past year and underwent heart-valve replacement surgery last week. The surgery was successful but he was unable to recover. Shankar lived in both India and the … India Pays Tribute to Ravi Shankar, Sitar Maestro and Cultural AmbassadorTIME India mourns ‘godfather of world music’The Australian Ravi Shankar dies at age 92 after heart and respiratory problemsZap2it.com (blog) Times of India –Daily News & Analysis –Bikya Masr all 1,827 news articles » |
Pre-Transplant Umbilical Cord Blood Expansion in Lab Speeds Establishment of New Blood Supply in Patients, Reducing …
Donated umbilical cord blood establishes a new blood supply in patients more quickly after transplantation when it is first expanded in the lab on a bed of cells that mimics conditions in the bone marrow, researchers report in the Dec. 13 edition of th…
Family believes in donating organs – Times of India
|
Family believes in donating organs
Times of India Anmol’s mother was inconsolable. While Anmol’s liver and two kidneys have already been transplanted, his heart valve, pancreas, cornea and at least 30 other organs have been preserved for transplant, said AIIMS officials. The transplants were carried … |
Hope hurdle for organ donation – Times of India
 Times of India |
Hope hurdle for organ donation
Times of India NEW DELHI: Lack of awareness about the consequences of brain death — irreversible loss of brain functions — is the main reason for India’s poor record in organ donation. While in countries like the US and Britain, 40% families agree to donate the … Organ donation – all your queries answeredIndia.Com Health First city hospitals picked for new national organ donation systemEastDay.com |
Live Music Sunday, Dec. 16 – The Providence Journal
Live Music Sunday, Dec. 16The Providence JournalThe R.A. Fish Duo, jazz and global, India, 1060 Hope St., Providence. 421-2600. 5-8 pm. Kenny G, jazz, Wilbur Theatre, 246 Tremont St., Boston. (800) 745-3000, livenation.com. 8 pm. $40-$49.50. Honky Tonk…
Older and younger chronic leukemia patients may need different therapy – Science Codex
|
Older and younger chronic leukemia patients may need different therapy
Science Codex “The study suggests that chlorambucil is superior to fludarabine in older patients, and that CD20 antibody therapies such as rituximab are beneficial as front-line therapy for all CLL patients, regardless of age,” says Byrd, who is the D. Warren Brown … |
A bitter bill to swallow, for life
Mumbai, Dec. 13 — For those suffering from lasting diseases such as diabetes and hepatitis, there is no respite from ever-increasing medical costs, and the damage these ailments do to vital organs such as the kidneys and liver often forces patients to…
New Combo Replaces CHOP for Lymphoma – MedPage Today
|
New Combo Replaces CHOP for Lymphoma
MedPage Today ATLANTA – Once the most common treatment for indolent non-Hodgkin’s Lymphoma, the combination chemotherapy known as CHOP is rapidly falling to the wayside in Germany – replaced by bendamustine (Treanda), frequently combined with rituximab … |
Anti–PD-1 Immunotherapy Shows Activity in Relapsed Lymphoma Patients – Cancer Network
|
Anti–PD-1 Immunotherapy Shows Activity in Relapsed Lymphoma Patients
Cancer Network The combination of rituximab (Rituxan) and the novel immunotherapy pidilizumab (CT-011) is both active and well tolerated in follicular lymphoma patients, according to results of a phase II trial presented by Jason R. Westin, MD, of the MD Anderson … |
Older and younger chronic leukemia patients may need different therapy – Medical Xpress
|
Older and younger chronic leukemia patients may need different therapy
Medical Xpress “The study suggests that chlorambucil is superior to fludarabine in older patients, and that CD20 antibody therapies such as rituximab are beneficial as front-line therapy for all CLL patients, regardless of age,” says Byrd, who is the D. Warren Brown … |